tetano
Editor, Senior Moderator
J Med Virol
. 2022 Jan 6.
doi: 10.1002/jmv.27574. Online ahead of print.
The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far
Md Sohan[SUP] 1 [/SUP], Md Jamal Hossain[SUP] 2 [/SUP], Md Rabiul Islam[SUP] 1 [/SUP]
Affiliations
Abstract
The SARS-CoV-2 Omicron (B.1.1.529) variant first emerged in early November 2021, has prompted worldwide fear due to its contagiousness and immunity escaping capacity. This article is protected by copyright. All rights reserved.
Keywords: B.1.1.529; COVID-19; Coronavirus; Covid-19 vaccines; Omicron; SARS-CoV-2.
This article is protected by copyright. All rights reserved.
. 2022 Jan 6.
doi: 10.1002/jmv.27574. Online ahead of print.
The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far
Md Sohan[SUP] 1 [/SUP], Md Jamal Hossain[SUP] 2 [/SUP], Md Rabiul Islam[SUP] 1 [/SUP]
Affiliations
- PMID: 34989403
- DOI: 10.1002/jmv.27574
Abstract
The SARS-CoV-2 Omicron (B.1.1.529) variant first emerged in early November 2021, has prompted worldwide fear due to its contagiousness and immunity escaping capacity. This article is protected by copyright. All rights reserved.
Keywords: B.1.1.529; COVID-19; Coronavirus; Covid-19 vaccines; Omicron; SARS-CoV-2.
This article is protected by copyright. All rights reserved.